Related references
Note: Only part of the references are listed.The clinical utility of next-generation sequencing for bone and soft tissue sarcoma
Charles A. Gusho et al.
ACTA ONCOLOGICA (2022)
Medical oncological treatment for patients with Gastrointestinal Stromal Tumor (GIST)-A systematic review
Charlotte Margareta Brinch et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy
Chrisann Kyi et al.
GYNECOLOGIC ONCOLOGY REPORTS (2021)
Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck Highlighting a Novel Fusion and Potential Diagnostic Pitfall
Darcy A. Kerr et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment
Weijie Chen et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Transient Response of Olaparib on Pulmonary Artery Sarcoma Harboring Multiple Homologous Recombinant Repair Gene Alterations
Chiao-En Wu et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Larotrectinib in a Patient With Advanced Pleomorphic Liposarcoma of the Uterus
Anisley Valenciaga et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target
Nathan D. Seligson et al.
NPJ PRECISION ONCOLOGY (2021)
Next Generation Sequencing Reveals Pathogenic and Actionable Genetic Alterations of Soft Tissue Sarcoma in Chinese Patients: A Single Center Experience
Gu Jin et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies
Evgeny Yakirevich et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Molecular Tumor Board Guides Successful Treatment of a Rare, Locally Aggressive, Uterine Mesenchymal Neoplasm
Elaine M. Walsh et al.
JCO PRECISION ONCOLOGY (2021)
NTRKfusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma
Joseph T. Rabban et al.
HISTOPATHOLOGY (2020)
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies
Roman Groisberg et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience
Ninna Aggerholm-Pedersen et al.
TRANSLATIONAL ONCOLOGY (2020)
Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss
Douglas Lin et al.
GYNECOLOGIC ONCOLOGY (2020)
Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study
Hiroshi Urakawa et al.
CANCER SCIENCE (2020)
Tumor mutation burden and checkpoint immunotherapy markers in primary and metastatic synovial sarcoma
Mai He et al.
HUMAN PATHOLOGY (2020)
A novel TJP1-ROS1 fusion in malignant peripheral nerve sheath tumor responding to crizotinib A case report
Juming Li et al.
MEDICINE (2020)
Phase I Study of P-cadherin-targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors
Vivek Subbiah et al.
CLINICAL CANCER RESEARCH (2020)
A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy
Angela C. Hirbe et al.
EUROPEAN JOURNAL OF CANCER (2020)
Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial
Patrick Arnaud-Coffin et al.
TRANSLATIONAL ONCOLOGY (2020)
Characteristics of mismatch repair deficiency in sarcomas
Leona A. Doyle et al.
MODERN PATHOLOGY (2019)
A Pilot Prospective Study of Refractory Solid Tumor Patients for NGS-Based Targeted Anticancer Therapy
Young Mi Seol et al.
TRANSLATIONAL ONCOLOGY (2019)
Basic Knowledge in Soft Tissue Sarcoma
Kevin Bourcier et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2019)
Targeted Treatment of a Rare Vaginal Sarcoma With an Anaplastic Lymphoma Kinase Inhibitor
Nolan Kinne et al.
OBSTETRICS AND GYNECOLOGY (2019)
Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach
Shumei Kato et al.
ONCOLOGIST (2018)
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients
Anne-Laure Giraudet et al.
BMC CANCER (2018)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes
Michael Cecchini et al.
LANCET ONCOLOGY (2018)
PET-CT evaluation of the curative effect of crizotinib on malignant myofibroblastoma with rare mutation of ALK R401: a case report and literature review
Li Yang et al.
ONCOTARGETS AND THERAPY (2018)
Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations
Neeta Somaiah et al.
Oncotarget (2018)
Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy
Bushra Weidenbusch et al.
Oncotarget (2018)
Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas Insights for Personalized Therapy
Carlo Lucchesi et al.
JAMA ONCOLOGY (2018)
A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report
Ning Zhou et al.
BMC CANCER (2018)
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic
Vikas Dembla et al.
Oncotarget (2018)
Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets
Jihyun Kim et al.
BMC MEDICAL GENETICS (2018)
Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis
A. Kollar et al.
ACTA ONCOLOGICA (2017)
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A Alteration
Julia A. Elvin et al.
ONCOLOGIST (2017)
Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas
Roman Groisberg et al.
ONCOTARGET (2017)
Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial
Anne C. Harttrampf et al.
CLINICAL CANCER RESEARCH (2017)
Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib
A. S. Mansfield et al.
ANNALS OF ONCOLOGY (2016)
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
Olivier Mir et al.
LANCET ONCOLOGY (2016)
Targeted Treatment of a Rare Vaginal Sarcoma With an Anaplastic Lymphoma Kinase Inhibitor
Gareth K. Forde et al.
OBSTETRICS AND GYNECOLOGY (2016)
Successful treatment of angiosarcoma of the scalp with apatinib: a case report
Guanghui Ji et al.
ONCOTARGETS AND THERAPY (2016)
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
Thomas Brodowicz et al.
BMC CANCER (2015)
STUMP unstumped: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
Vivek Subbiah et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Response of refractory Ewing sarcoma to pazopanib
Thierry Alcindor
ACTA ONCOLOGICA (2015)
Pazopanib in metastatic osteosarcoma: Significant clinical response in three consecutive patients
Akmal Safwat et al.
ACTA ONCOLOGICA (2014)
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali et al.
ANNALS OF ONCOLOGY (2014)
Systemic treatment of soft-tissue sarcoma -gold standard and novel therapies
Mark Linch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
C. A. Stiller et al.
EUROPEAN JOURNAL OF CANCER (2013)
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
Winette T. A. van der Graaf et al.
LANCET (2012)
Share Paper
